-10.65% percent quarterly performance for KalVista Pharmaceuticals Inc (KALV) is not indicative of the underlying story
On Friday, KalVista Pharmaceuticals Inc (NASDAQ: KALV) was -4.64% drop from the session before settling in for the closing price of $11.00. A 52-week range